CCER2

Model summary

A human adaptor-like regulator that concentrates on secretory granules to organize protein assemblies governing the regulated secretory pathway. By using multivalent binding rather than catalysis, it scaffolds cargo sorting and exocytic machinery to promote hormone release under appropriate stimuli while restraining secretion when pathways favor storage or retrieval. The same assembly capacity likely interfaces with transcriptional corepressors to dampen gene expression programs, coupling vesicle trafficking with broader cellular signaling and secretion control.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The sequence carries a single annotated feature: GO:0005515 protein binding as its molecular-function label. The absence of catalytic InterPro domains and the presence of a generic binding label indicate a non-enzymatic, adaptor-like role. A solitary binding-centric architecture typically encodes scaffolding or cargo-organizing functions rather than enzymatic chemistry. This architecture causally supports multivalent protein association that modulates trafficking and secretion pathways.

2. 02

   From this binding-centric core, I infer molecular function first.

   A scaffold that lacks catalytic motifs but is optimized for assembly implies GO:0005515 protein binding as the operative activity. Such binding modules often couple to coat/adaptor complexes, SNARE machinery, and calcium-responsive effectors that govern regulated exocytosis.

3. 03

   This binding role drives the biological processes observed.

   The protein’s association with the regulated secretory pathway explains GO:0009306 protein secretion. Its ability to tune vesicle biogenesis and cargo handling accounts for bidirectional control of secretion: GO:0046887 positive regulation of hormone secretion and GO:0051048 negative regulation of secretion by cell, consistent with context-dependent assembly of exocytic versus endocytic modules. The same scaffolding logic extends to transcriptional control: by sequestering or recruiting transcriptional regulators, the protein can dampen gene expression programs, aligning with GO:0045892 negative regulation of DNA-templated transcription. Together, these processes position the protein at the interface of vesicle trafficking and signaling-responsive gene regulation.

4. 04

   Cellular localization follows from the trafficking logic.

   The explicit association with the regulated secretory route places the protein in GO:0030141 secretory granule. A binding-driven adaptor concentrated on secretory granules can coordinate cargo sorting, granule maturation, and stimulus-coupled exocytosis. This localization is reinforced by the absence of transmembrane domains and the need for dynamic assembly/disassembly on cytoplasmic faces of granule membranes.

5. 05

   Mechanistically, I propose that the protein acts as a granule-proximal scaffold that nucleates complexes controlling regulated secretion.

   By binding multiple partners, it stabilizes granule cargo and couples to Ca2+-responsive exocytic machinery to enhance hormone release under appropriate stimuli while restraining secretion when pathways favor retrieval or storage. The same assemblies may transiently engage nuclear or cytoplasmic transcriptional modulators, explaining transcriptional repression. Likely interaction partners include adaptor complexes (e.g., AP complexes), vesicle tethers and SNAREs, calcium sensors, and transcriptional corepressors—all consistent with a granule-enriched, binding-driven regulator of secretion and gene expression.